share_log

Ziegler Capital Management LLC Grows Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Ziegler Capital Management LLC Grows Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

齊格勒資本管理公司增持默裡特醫療系統公司(納斯達克代碼:MMSI)
Financial News Live ·  2023/01/02 09:41

Ziegler Capital Management LLC lifted its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) by 0.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 201,908 shares of the medical instruments supplier's stock after buying an additional 1,816 shares during the quarter. Ziegler Capital Management LLC owned approximately 0.36% of Merit Medical Systems worth $11,410,000 at the end of the most recent quarter.

Ziegler Capital Management LLC在最近一次向美國證券交易委員會(SEC)披露的信息中稱,該公司第三季度將其在納斯達克(Sequoia Capital Systems,Inc.)股票的持倉量上調了0.9%。該機構投資者在本季度額外購買了1,816股後,持有這家醫療器械供應商的201,908股票。截至最近一個季度末,Ziegler Capital Management LLC擁有Merit Medical Systems約0.36%的股份,價值11,410,000美元。

A number of other institutional investors have also modified their holdings of MMSI. Lindbrook Capital LLC grew its stake in Merit Medical Systems by 148.4% in the 2nd quarter. Lindbrook Capital LLC now owns 477 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 285 shares during the period. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in shares of Merit Medical Systems in the second quarter valued at $37,000. Quantbot Technologies LP acquired a new position in Merit Medical Systems in the first quarter valued at $43,000. First Horizon Advisors Inc. lifted its position in Merit Medical Systems by 56.2% during the second quarter. First Horizon Advisors Inc. now owns 1,287 shares of the medical instruments supplier's stock worth $70,000 after buying an additional 463 shares during the period. Finally, Eagle Bay Advisors LLC boosted its stake in Merit Medical Systems by 87.0% in the 2nd quarter. Eagle Bay Advisors LLC now owns 1,870 shares of the medical instruments supplier's stock worth $101,000 after buying an additional 870 shares during the last quarter. Institutional investors and hedge funds own 95.38% of the company's stock.

其他一些機構投資者也調整了對MMSI的持股。林德布魯克資本有限責任公司在第二季度增持了148.4%的Merit醫療系統股份。Lindbrook Capital LLC在此期間額外收購了285股,現在擁有這家醫療器械供應商477股股票,價值2.6萬美元。Harel Insurance Investments&Financial Services Ltd.在第二季度購買了價值3.7萬美元的Merit Medical Systems新股。Quantbot Technologies LP在第一季度收購了Merit醫療系統公司的一個新頭寸,價值4.3萬美元。First Horizon Advisors Inc.在第二季度將其在Merit Medical Systems的頭寸提高了56.2%。First Horizon Advisors Inc.現在持有這家醫療器械供應商1,287股股票,價值7萬美元,在此期間又購買了463股。最後,Eagle Bay Advisors LLC在第二季度將其在Merit Medical Systems的持股增加了87.0%。Eagle Bay Advisors LLC現在擁有這家醫療器械供應商1,870股股票,價值101,000美元,上個季度又購買了870股。機構投資者和對衝基金持有該公司95.38%的股票。

Get
到達
Merit Medical Systems
優點醫療系統
alerts:
警報:

Merit Medical Systems Price Performance

優點醫療系統性價比

Shares of MMSI opened at $70.62 on Monday. The company has a current ratio of 2.35, a quick ratio of 1.19 and a debt-to-equity ratio of 0.19. The firm has a market cap of $4.02 billion, a price-to-earnings ratio of 65.39, a PEG ratio of 2.50 and a beta of 1.01. Merit Medical Systems, Inc. has a 52 week low of $50.46 and a 52 week high of $76.14. The stock has a 50 day moving average of $69.67 and a 200-day moving average of $61.48.

週一,MMSI的股價開盤報70.62美元。該公司的流動比率為2.35,速動比率為1.19,債務權益比率為0.19。該公司市值為40.2億美元,市盈率為65.39倍,聚乙二醇率為2.50倍,貝塔係數為1.01。Merge Medical Systems,Inc.的52周低點為50.46美元,52周高點為76.14美元。該股的50日移動均線切入位在69.67美元,200日移動均線切入位在61.48美元。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last released its earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.11. Merit Medical Systems had a net margin of 5.43% and a return on equity of 14.14%. The firm had revenue of $287.18 million during the quarter, compared to analyst estimates of $273.03 million. As a group, analysts forecast that Merit Medical Systems, Inc. will post 2.57 EPS for the current year.
優點醫療系統公司(納斯達克代碼:MMSI-GET Rating)最近一次公佈財報是在10月26日星期三。這家醫療器械供應商公佈本季度每股收益為0.64美元,比普遍預期的0.53美元高出0.11美元。優點醫療系統公司的淨利潤率為5.43%,股本回報率為14.14%。該公司本季度營收為2.8718億美元,而分析師預期為2.7303億美元。分析師預測,作為一個整體,Merit Medical Systems,Inc.本年度每股收益將達到2.57美元。

Analyst Upgrades and Downgrades

分析師升級和下調評級

A number of equities analysts have weighed in on the company. Raymond James upped their price target on Merit Medical Systems from $71.00 to $72.00 and gave the stock an "outperform" rating in a report on Thursday, October 27th. Piper Sandler upped their price objective on shares of Merit Medical Systems from $70.00 to $73.00 in a research report on Thursday, October 27th. Canaccord Genuity Group cut Merit Medical Systems from a "buy" rating to a "hold" rating and cut their price target for the stock from $73.00 to $72.00 in a research note on Tuesday, December 20th. StockNews.com lowered Merit Medical Systems from a "strong-buy" rating to a "buy" rating in a research note on Monday, December 26th. Finally, Canaccord Genuity Group increased their target price on Merit Medical Systems from $69.00 to $73.00 in a research note on Monday, November 7th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $73.50.

許多股票分析師對該公司進行了分析。雷蒙德·詹姆斯在10月27日週四的一份報告中將Merit Medical Systems的目標價從71.00美元上調至72.00美元,並給予該股“跑贏大盤”的評級。在10月27日星期四的一份研究報告中,派珀·桑德勒將Merit醫療系統公司的股票目標價從70.00美元上調至73.00美元。在12月20日星期二的一份研究報告中,Canaccel Genuity Group將Merit Medical Systems的評級從“買入”下調至“持有”,並將該股的目標價從73.00美元下調至72.00美元。在12月26日星期一的一份研究報告中,StockNews.com將Merit Medical Systems的評級從“強力買入”下調至“買入”。最後,Canaccel Genuity Group在11月7日星期一的一份研究報告中將Merit Medical Systems的目標價從69.00美元上調至73.00美元。一位股票研究分析師將該股評級為持有,五位分析師給予該股買入評級。根據MarketBeat.com的數據,該公司的平均評級為“適度買入”,共識目標價為73.50美元。

Merit Medical Systems Company Profile

優點醫療系統公司簡介

(Get Rating)

(獲取評級)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

優點醫療系統公司設計、開發、製造和營銷用於介入、診斷和治療程序的一次性醫療產品,主要用於心臟病學、放射學、腫瘤學、危重護理和內窺鏡檢查。該公司在心血管和內窺鏡兩個領域開展業務。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Should You Warm up to Generac Stock for the Winter?
  • Is Kintara Therapeutics A Hidden Gem?
  • 免費獲取StockNews.com關於Merit Medical Systems(MMSI)的研究報告
  • MarketBeat:回顧一週12/26-12/30
  • 科技狗:是時候咬一口這些股票了
  • 這筆收購會讓微軟成為熊市買入者嗎?
  • 你應該熱身到Generac股票過冬嗎?
  • 金塔拉治療公司是一顆隱藏的寶石嗎?

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating).

想看看還有哪些對衝基金持有MMSI嗎?訪問HoldingsChannel.com獲取Merit Medical Systems,Inc.(納斯達克代碼:MMSI-GET Rating)的最新13F備案文件和內幕交易信息。

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新聞和評級的優點醫療系統每日-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Merit Medical Systems和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論